共 34 条
Enrichment of Human Embryonic Stem Cell-Derived NKX6.1-Expressing Pancreatic Progenitor Cells Accelerates the Maturation of Insulin-Secreting Cells In Vivo
被引:204
作者:
Rezania, Alireza
[1
]
Bruin, Jennifer E.
[2
]
Xu, Jean
[1
]
Narayan, Kavitha
[1
]
Fox, Jessica K.
[2
]
O'Neil, John J.
[1
]
Kieffer, Timothy J.
[2
,3
]
机构:
[1] Janssen R&D LLC, BetaLog Venture, Raritan, NJ USA
[2] Univ British Columbia, Lab Mol & Cellular Med, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada
来源:
基金:
加拿大健康研究院;
关键词:
Diabetes;
Beta cells;
Human embryonic stem cells;
Cell therapy;
Transplantation;
ISLET TRANSPLANTATION;
BETA-CELLS;
GLUCOSE-TRANSPORTER;
MICE;
GENERATION;
MAFA;
DIFFERENTIATION;
EXPRESSION;
D O I:
10.1002/stem.1489
中图分类号:
Q813 [细胞工程];
学科分类号:
摘要:
Human embryonic stem cells (hESCs) are considered a potential alternative to cadaveric islets as a source of transplantable cells for treating patients with diabetes. We previously described a differentiation protocol to generate pancreatic progenitor cells from hESCs, composed of mainly pancreatic endoderm (PDX1/NKX6.1-positive), endocrine precursors (NKX2.2/synaptophysin-positive, hormone/NKX6.1-negative), and polyhormonal cells (insulin/glucagon-positive, NKX6.1-negative). However, the relative contributions of NKX6.1-negative versus NKX6.1-positive cell fractions to the maturation of functional -cells remained unclear. To address this question, we generated two distinct pancreatic progenitor cell populations using modified differentiation protocols. Prior to transplant, both populations contained a high proportion of PDX1-expressing cells (approximate to 85%-90%) but were distinguished by their relatively high (approximate to 80%) or low (approximate to 25%) expression of NKX6.1. NKX6.1-high and NKX6.1-low progenitor populations were transplanted subcutaneously within macroencapsulation devices into diabetic mice. Mice transplanted with NKX6.1-low cells remained hyperglycemic throughout the 5-month post-transplant period whereas diabetes was reversed in NKX6.1-high recipients within 3 months. Fasting human C-peptide levels were similar between groups throughout the study, but only NKX6.1-high grafts displayed robust meal-, glucose- and arginine-responsive insulin secretion as early as 3 months post-transplant. NKX6.1-low recipients displayed elevated fasting glucagon levels. Theracyte devices from both groups contained almost exclusively pancreatic endocrine tissue, but NKX6.1-high grafts contained a greater proportion of insulin-positive and somatostatin-positive cells, whereas NKX6.1-low grafts contained mainly glucagon-expressing cells. Insulin-positive cells in NKX6.1-high, but not NKX6.1-low grafts expressed nuclear MAFA. Collectively, this study demonstrates that a pancreatic endoderm-enriched population can mature into highly functional -cells with only a minor contribution from the endocrine subpopulation. Stem Cells2013;31:2432-2442
引用
收藏
页码:2432 / 2442
页数:11
相关论文